Form 4: Bioxytran Director Anders Utter Acquires Shares in Company

Anders Utter, a director at Bioxytran, Inc. (BIXT), acquired 20,619 preferred shares at $0.46 per share on October 25, 2024.

Summary

• On October 25, 2024, Anders Utter, a director of Bioxytran, Inc., acquired 20,619 preferred shares of the company at a price of $0.46 per share.
• Following this transaction, Utter directly owns 236,457 preferred shares of Bioxytran, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a transaction by a company insider. The purchase itself could be seen as slightly positive, but the document is primarily informational.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade in their company's stock. It provides transparency to the market about insider transactions.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates

Keywords

Bioxytran, Director, Share Acquisition, BIXT, Anders Utter, Preferred Shares, Form 4